suppressed cell cycle progression in the G 1 phase and induced astrocytic differentiation in vitro in the presence of the extracellular matrix (ECM).
Materials and Methods

Cell Line and Culture Condition
The four human glioma cell lines (T98G, U-251MG, U-87MG, and A172) selected for use in this study were derived from glioblastomas and were obtained from the American Type Culture Collection. 54, 55 It has been reported that T98G, U-251MG, and U-87MG cells had PTEN mutations, and A172 cells had an intragenic homozygous deletion of PTEN. Using polymerase chain reaction (PCR) and DNA sequencing, we confirmed that the PTEN alterations described previously were actually present in the cell lines that we used. Cells were maintained and passaged in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal calf serum and kept at 37˚C in a humidified atmosphere of 5% carbon dioxide and 95% air. For differentiation studies, cells were plated on 35-mm round plastic dishes coated with 100 g/cm 2 of Matrigel basement membrane matrix at a final density of 10 4 cells/ml.
Plasmid Generation
A wild-type PTEN expression vector, pcDNA-PTEN, was constructed as follows. First-strand PTEN complementary (c)DNA was synthesized using the messenger RNA of normal human bronchial epithelium by reverse transcription-PCR. Wild-type PTEN cDNA was amplified by PCR and cloned into the EcoRI site of mammalian expression vector pcDNA3 containing the human cytomegalovirus (CMV) promoter and neomycin-resistant sequence. The wild-type PTEN cDNA sequence was verified by DNA sequencing.
For an inducible PTEN expression system, we constructed pTAHyg by ligating the hygromycin-resistance gene from pHyg to pUHD15-1, which carries a chimeric gene encoding a fusion protein between the Tc repressor of the Tn10 Tc-resistance operon of Escherichia coli and the activating domain of virion protein 16 of the herpes simplex virus. 2, 23 The fusion protein (tTA) acts as a transactivator that stimulates the transcription from a minimal promoter sequence derived from the human CMV promoter IE combined with tet operator sequences (PhCMV-tetO). We also constructed pT2-neo by modifying the multicloning site of pUHD10-3 that carries a PhCMV-tetO sequence and ligating the neomycin-resistant gene into it. 2, 23 To generate a plasmid expressing a FLAG epitope-tagged PTEN, we inserted the sequence GACTACAAGGACGACGATGACAAG encoding the FLAG epitope into the PTEN cDNA between the first and second amino acids. 4 Briefly, the FLAG epitope-tagged PTEN cDNA fragment was created by PCR amplification of the coding region from pcDNA-PTEN by using an upstream primer (5Ј-ACG-CGTCGACATGACTACAAGGACGACGATGACAAGACA-GCCATCATCAAAGAGATC-3Ј) containing at its 5Ј terminus a SalI restriction site, a methionine followed by a sequence encoding the FLAG epitope, and a downstream primer (5Ј-CGGGATCCT-CAGACTTTTGTAATTTGTGTATG-3Ј) containing a 3Ј BamHI site. The wild-type PTEN cDNA sequence was reconfirmed by DNA sequencing. The pT2FLAG-PTEN was finally constructed by ligating the FLAG epitope-tagged PTEN cDNA fragment into pT2-neo (Fig. 1) .
Cell Transfection
Cells were transfected with plasmid pcDNA-PTEN or pcDNA3 (no insert) in triplicate dishes and in three independent experiments by using the lipofection method according to the manufacturer's protocol. We seeded 10 6 parental cells into a 100-mm culture dish and incubated them in a 5-ml minimum essential medium (MEM) with 30 l of lipofectoamine and 1.37 pmol of the expression vectors. Transfections were terminated after 7 and 48 hours, cells were split at a 1:5 dilution and exposed for 14 to 21 days in G418-containing medium. The plates were subsequently washed in phosphate-buffered saline, fixed in 10% methanol and 10% acetic acid, and stained with 20% ethanol and 0.4% crystal violet. The total number of colonies represented the transfection efficiency. Oneway analysis of variance was used for statistical analysis of the results.
To establish clones with inducible PTEN expression, parental cells were first transfected with the effector plasmid pTA-Hyg by lipofectoamine. We seeded 4 ϫ 10 5 parental cells into a 35-mm culture dish and incubated them in 2 ml of MEM with 10 l of lipofectoamine and 1 g of pTA-Hyg. Five hours after transfection, the MEM was replaced by 2 ml of the medium supplemented with 20% fetal calf serum. After 48 hours, cells were seeded at a density of 10 4 cells/100-mm culture dish and exposed to hygromycin. After 3 weeks of selection, each of the hygromycin-resistant colonies was transferred separately to an individual well in a 24-well plate. We subsequently expanded the cells and tested for Tc-controlled expression of tTA by transient transfection with pT2GN, a PhCMVtetO-␤-galactosidase reporter construct, in the presence or absence of 1 g/ml Tc. Although we could not obtain U-251MG-, U-87MG-, or A172-derived clones with high Tc transactivator expression, we successfully established T98G-derived T98G-TA9, which exhibited a 20-fold increase in ␤-galactosidase activity after 72 hours in culture without Tc.
Second, T98G-TA9 cells were transfected by lipofectoamine with plasmid pT2FLAG-PTEN. Cells were selected in medium containing 0.3 mg/ml of hygromycin and 0.8 mg/ml of G418 in the presence of 1 g/ml Tc. Hygromycin-and G418-resistant colonies were cloned and subsequently expanded for further analyses.
Western Blot Analysis
Cellular protein was extracted by lysing 10 6 cells with 40 l of lysis buffer (50 mM HEPES-NaOH, pH 7, 1% Nonidet P-40, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 250 mM NaCl, 5 mM ethylenediaminetetraacetic acid, 50 mM NaF, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, and 50 g/ml aprotinin). Fifty micrograms of total protein was separated in a 4 to 20% gradient SDS/polyacrylamide gel and electroblotted to an Immobilon polyvinylidene difluoride microporous membrane. Equal loading of protein was confirmed by staining the membrane after detection. After being blocked with 5% nonfat dry milk and 0.1% Tween 20 in Tris-buffered saline, membranes were incubated at 37˚C for 2 hours with a 1:400 dilution of an anti-FLAG M2 monoclonal antibody or with a 1:200 dilution of glial fibrillary acidic protein (GFAP)-specific monoclonal antibody. The blot was subsequently probed using the ECL-Plus Western blotting detection system.
In Vitro Growth Rate
Cells were assayed for viability by using the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay as described by Mosmann. 40 Equal numbers of cells from individual clones were seeded in 24-well plates at a density of 5 ϫ 10 3 cells per well and cultured with 1 ml of culture medium in the presence or absence of 1 g/ml Tc (Day 0). The MTT was added to the cultures (500 mg/ml) and incubated at 37˚C for 4 hours. The intracellular formazan crystals were solubilized with dimethyl sulfoxide and the absorbance of the solution at 560 nm was measured using a spectrophotometer. The wells were harvested on each of Days 1 through 7. Doubling times were calculated from lines fitted to log cell numbers by linear regression analysis.
Cell Cycle Analysis
Cells were released into growth media in the presence or absence of 1 g/ml Tc. At 0, 48, and 72 hours, cells were harvested and fixed in 10 ml of 50% ethanol for at least 30 minutes at 4˚C. When the treatment with nocodazole was performed, this reagent was added to a final concentration of 40 ng/ml at 24 hours after induction and the cells were incubated for an additional 24 hours, followed by fixation. The cells were treated with 5 mg/ml RNase A, stained with 50 g/ml propidium iodide, and analyzed using flow cytometry for DNA synthesis and cell cycle status. The flow cytometric assay was performed with a fluorescence-activated cell sorter (FACS). The FACS profiles of cells were calculated using commercially available software.
Sources of Supplies and Equipment
Dulbecco's modified Eagle's medium was purchased from Nissui, Tokyo, Japan. Matrigel basement membrane matrix was acquired from Collaborative Biomedical Products, Bedford, MA. The mammalian expression vector pcDNA3 was obtained from Invitrogen, Carlsbad, CA. The lipofection materials were purchased from Gibco, Grand Island, NY, as were the Opti-MEM and the G418-containing medium (Geneticin). The hygromycin was obtained from Calbiochem, La Jolla, CA, and the nocodazole from Aldrich, St. Louis, MO. The microporous membranes (Immobilon) were purchased from Millipore Corp., Bedford, MA. The anti-FLAG M2 monoclonal antibody was acquired from Scientific Imaging Systems, a division of Eastman Kodak, Rochester, NY. The GFAP-specific monoclonal antibody, RNase A, and propidium iodide were obtained from Sigma Chemical Co., St. Louis, MO. The Western blotting detection system (ECL-Plus) was purchased from Amer- 
Results
Growth Suppression by the Exogenous PTEN Gene
To test whether the PTEN gene has growth-suppressive properties in glioma cells, we introduced wild-type PTEN cDNA separately into each of four human glioma cell lines: T98G, U-87MG, and U-251MG, which have PTEN mutations, and A172, in which PTEN is homozygously deleted. After completion of G418 selection, growth suppression was quantified by comparing the number of G418-resistant colonies in cultures transfected with PTEN wild-type alleles to those in cultures transfected with empty vector. As shown in Fig. 2 , the colony number was significantly reduced in the transfection of the PTEN gene, to 15% Ϯ 1.4% (mean Ϯ standard error) of vector control for T98G, 29.1% Ϯ 2.6% for U-251MG, 32.9% Ϯ 3.5% for U-87MG, and 20.2% Ϯ 1.3% for A172. Thus, in glioma cells with the aberrant PTEN genes, introduction of the wild-type PTEN gene resulted in reduction of colony number, suggesting that the PTEN gene could function as a growth suppressor in human glioma cells.
Isolation of Glioma Cells That Conditionally Express PTEN Protein
To further investigate the biological function of PTEN protein in glioma cells, we attempted to establish clones in which expression of the wild-type PTEN gene could be regulated under Tc control. As described in Materials and Methods, we transfected the FLAG epitope-tagged wildtype PTEN gene expression vector pT2FLAG-PTEN into T98G-derived T98G-TA9 cells that expressed high levels of the Tc transactivator. A number of hygromycin and G418-resistant clones were isolated, and expression of the exogenous PTEN gene was analyzed using Western blotting in the absence of Tc; in the induced state of the introduced gene. We were able to obtain several clones that showed detectable levels of PTEN protein after the removal of Tc from the growth medium and not when cultured in the presence of Tc (in the repressed state). Among them, T98G-PTEN 1 and -PTEN 2 clones expressed comparatively high levels of PTEN protein in the induced state (Fig. 3 ) and these two clones had stable inducibility. Timecourse analysis of the PTEN protein induction revealed that the amount of PTEN protein reached a maximum at 48 hours after Tc wash out and was steady for up to 96 hours (data not shown).
Effect of PTEN Expression on Cell Growth and Morphology
By using these clones with inducible expression of PTEN protein, we evaluated the effect of the PTEN gene on the growth of T98G cells by MTT assay. Growth rates of T98G-PTEN 1 and -PTEN 2 cells were not significantly reduced during 24 hours of exogenous PTEN expression. However, those clones demonstrated a gradual decrease in growth rates after 48 hours of PTEN induction. The growth of control clone T98G-PTEN-N, which was isolated following transfection by plasmid pT2FLAG-PTEN and was negative for PTEN expression, was not suppressed after the removal of Tc (Fig. 4) .
Alterations in cell morphology were also examined in T98G-PTEN 1 and -PTEN 2 cells. Microscopic examination revealed that PTEN-induced cells displayed none of the overt features of cell death, such as chromatin condensation, nuclear fragmentation, or cytoplasmic boiling.
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3 cells/ml in 1 ml of culture medium in the individual wells of 24-well plates. At each indicated time point (every 24 hours), cell viability was determined and represented as the degree of absorbance by MTT assay. The mean absorbances per triplicate wells were plotted against the number of days after seeding. Bars = standard deviation.
Other distinct morphological changes were not seen in cells after exogenous PTEN induction in normal cultivation.
Effect of PTEN Expression on the Cell Cycle of Exponentially Growing Cells
Because PTEN expression did not induce cell death into T98G cells, the PTEN-mediated growth suppression of T98G cells could be caused by inhibition of cell cycle progression at a specific phase. Therefore, we next analyzed alterations in cell cycle distribution of exponentially growing T98G cells after PTEN induction by using flow cytometry.
Time-course analysis was performed in the presence (+) and absence (Ϫ) of Tc (Fig. 5A, Table 1 ). At 48 hours after induction, both T98G-PTEN 1 and -PTEN 2 cells showed marked increases in the percentage of G 1 phase cells, whereas the population of S phase cells was reduced to 48% and 52% of that of the respective uninduced cells ( Table 1 ). The percentage of G 1 -arrested cells increased further after an additional 24 hours. However, there was no evidence for the presence of G 2 /M arrest or a sub-G 1 peak characteristic of apoptosis in the absence of Tc. The control clone T98G-PTEN-N was not significantly changed by Tc.
To further investigate whether cells were arrested at the G 1 phase by exogenous PTEN expression, we added nocodazole to PTEN-induced cells. Nocodazole is one of rapidly reversible inhibitors of microtubule polymerization that can block the cell cycle at the G 2 /M phase and thus prevents the cells from cycling back from this phase to the G 1 phase. 11, 59 Cells exposed to the induced state for 24 hours were treated with nocodazole for an additional 24 hours (48 hours after PTEN induction), followed by flow cytometric analysis. As shown in Fig. 5B and Table  1 , a significant number of PTEN-induced cells remained at the G 1 phase, whereas most of the uninduced cells progressed to the G 2 /M phase at 24 hours after nocodazole treatment. These results indicate that PTEN protein suppressed the growth of T98G cells by inducing G 1 arrest.
Differentiation Induced by PTEN Expression
The PTEN gene is homologous with tensin, a cytoskeletal protein that binds to actin filaments at focal adhesions; complexes that contain integrins; focal adhesion kinase; Src; and growth factor receptors. 9, 39, 58 It has also been shown that PTEN could regulate cell interactions with ECM proteins through integrin receptors. 51 Therefore, we attempted to culture cells on dishes coated with Matrigel, which was rich in ECM components containing laminin, collagen IV, heparan sulfate proteoglycan, and entactin, 28 and assessed the effect of exogenous PTEN on T98G cells in the presence of the ECM.
When plated onto Matrigel-coated dishes in the absence of Tc, T98G-PTEN 1 and -PTEN 2 cells showed striking features. At 72 hours after PTEN induction, most of the PTEN-induced cells extended multiple and long cytoplasmic processes compared with their counterparts cultured in the uninduced state (Fig. 6) . The morphological fea- Table 1 . A: Cells were incubated in the presence or absence of 1 g/ml Tc at 37˚C, then harvested at the indicated time points, stained with propidium iodide, and analyzed using the flow cytometer. B: Cells were incubated in the presence or absence of 1 g/ml Tc at 37˚C for 24 hours, and then treated with 40 ng/ml nocodazole for an additional 24 hours before harvesting. The rest of the procedure was performed as described in A. tures seen in these clones were similar to those of normal astrocytes. Then, to determine whether PTEN-induced T98G cells undergo differentiation, we further analyzed the level of GFAP, an intermediate filament protein specifically expressed in differentiated astrocytes. 17, 34 Western blot analysis of GFAP expression was performed for cell extracts prepared from T98G-PTEN 1 and -PTEN 2 cells when cultured in the presence or absence of Matrigel. Parental T98G cells and uninduced cells showed low or undetectable levels of GFAP, and induction of PTEN did not upregulate the level of GFAP in clones cultured on dishes not coated with Matrigel (Fig. 7) . However, GFAP expression was apparently increased by exogenous PTEN expression in clones cultured on Matrigel-coated dishes. These results indicated that PTEN expression induced astrocytic differentiation of T98G cells in vitro in the presence of the ECM. The band with the slowest migration rates indicated a molecular mass slightly greater than 50 kD. The bands with faster migration rates may represent breakdown products of GFAP. The presence of multiple bands on Western blots performed using GFAP antibody has been reported by others.
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Discussion
The present experiments showed that exogenous PTEN expression suppressed the growth of four human glioma cell lines with abnormal PTEN alleles. Our results are compatible with those of the previous studies. Furnari, et al., 20 reported that reduction of transfection efficiency was observed in two PTEN-mutated cultured glioma cell lines in which wild-type PTEN was introduced using plasmid vectors. Cheney, et al., 8 showed in vivo growth inhibition activity of PTEN in a glioma cell by using a recombinant adenoviral gene transfer system. However, the mode of action for suppression was not clarified because the biological effects of PTEN on malignant phenotypes of glioma cells have not been examined. If the restoration of PTEN function suppresses the growth of glioma cells, the exogenous PTEN transfectants should disappear during the transfection and selection procedures. As expected, we could not obtain transfectants in which the exogenous PTEN gene was stably expressed. Therefore, to investigate the biological function of PTEN, we established PTEN-inducible clones by using the Tc-inducible expression system in which exogenous PTEN expression was tightly regulated by Tc. In this study we demonstrated that PTEN expression in T98G glioma cells led to an arrest in the G 1 phase of the cell cycle and astrocytic differentiation in the presence of ECM. To further clarify these findings at the single cell level, we are currently investigating whether the phenotypic alterations observed here were caused by exogenous functional PTEN protein within individual cells.
Coordination of cell cycle progression is achieved by a series of changes in the cyclin-cyclin-dependent kinase (CDK) complexes. 25 In the case of progression from G 1 into S phase, one critical target of the activated cyclin-CDK complexes is Rb protein. This protein is bound to the transcription factor E2F during the G 1 phase, but on phosphorylation, E2F is released and activates the transcription of genes required for transition into the S phase. 6, 57 In this study, when exogenous PTEN expression induced G 1 arrest in T98G cells, we did not find the distinct changes of the Rb phosphorylation pattern of cells on Western blot analysis (data not shown). This result indicates that PTEN-mediated growth suppression could be exhibited through a pathway other than RB. This protein is not always essential for the induction of G 1 arrest because p53, which is situated upstream of Rb in control of the cell cycle, was able to induce G 1 arrest but not apoptosis in a subset of tumor cells lacking Rb function. 1, 7, 13 More recently, PTEN has been shown to catalyze in vitro dephosphorylation of phosphatidylinositol-3,4,5-trisphosphate (PIP3), a product of phosphatidylinositol 3-kinase (PI3K). 36 It has been reported that functional PI3K was required for G 1 to S progression in cells and that PIP3 activated Akt or protein kinase B, which encouraged cells to enter and progress through the cell cycle.
14,47 Therefore, PI3K/PIP3-mediated signaling is one of the cell's major growth control pathways. By removing the phosphate from PIP3, PTEN may block this pathway, which plays an important role in G 1 cell cycle pregression. Furnari, et al., 19 demonstrated that transient expression of PTEN mediated G 1 arrest in U-87MG and U178 glioma cells under reduced serum conditions. However, in our assay system, induction of PTEN led to G 1 arrest in T98G glioma cells even with high serum concentration. The difference could be caused by the differences of the gene transfer method, the amount of the introduced PTEN gene expression, and/ or the sensitivity of the cells against expression of the introduced PTEN gene. Further studies are now in progress to clarify these issues.
The link between cell differentiation and the expression of PTEN was suggested by Di Cristofano, et al. 12 They showed that PTEN Ϫ/Ϫ embryonic stem cells formed aberrant embryoid bodies that included a disorganized layer and displayed an altered ability to differentiate into endodermal, ectodermal, and mesodermal derivatives. However, there have been no reports that PTEN expression induced differentiation of undifferentiated tumor cells. We investigated the possibility that the glioma cells were differentiated by PTEN expression. The differentiation of glioma cells has been evaluated by morphological observations and by quantitative analysis of GFAP. Expression of GFAP, a glia-specific protein, occurs in astrocytes and differentiated astrocytomas, whereas its expression is often lost in malignant gliomas. 17, 34, 48 In this study we have demonstrated that morphological changes typical of astrocytic differentiation were observed, and GFAP expression was increased in T98G glioma cells by exogenous PTEN expression in the presence of the ECM. The differentiation we observed was considered to have been induced by PTEN itself, but not as a result of growth arrest, because serum-starved or CDK inhibitor p16 (CDKN2A)-expressing T98G cells showed growth inhibition caused by G 1 arrest but no differentiation on Matrigel-coated dishes (unpublished data). Thus, our findings were the first evidence that PTEN expression induced differentiation of undifferentiated glioma cells. It has been shown that PTEN overexpression inhibited cell migration, integrin-mediated cell spreading, and the formation of focal adhesions, 51 suggesting that PTEN functions as a tumor suppressor by negatively regulating dynamic cell-surface interactions. Accordingly, PTEN may promote cell differentiation by modulating cell interactions with the ECM. However, we have not obtained conclusive data that PTEN expression itself is enough to induce terminal differentiation in glioma cells, and besides, the molecular mechanism of PTEN-induced astrocytic differentiation is unknown. It is necessary to further elucidate the role of the PTEN gene in astrocytic differentiation.
There is increasing evidence that the development of gliomas is closely associated with a cumulative acquisition of multiple genetic alterations including inactivation of tumor suppressor genes. 10, 27, 44, 49 In addition to alterations of the PTEN gene, abnormalities of the p16 and p53 tumor-suppressor genes are frequently observed during human glioma progression. 18, 43, 49 These results indicate that the defects in at least three different growth-control pathways involving p16, p53, and PTEN are necessary for glioma cells to acquire malignant potentials. Inactivation of p16 has been shown to permit cells to escape from G 1 arrest of cell cycle regulation, resulting in unregulated growth. 3, 25 It has also been demonstrated that p53 inactivation allows cells to grow without apoptosis and without cell cycle arrest and results in immortalization. 22, 30, 38 Because PTEN alterations are mainly restricted to advanced gliomas and considering the biological evidence presented here, we suggest that PTEN inactivation contributes to further malignant transformation of glioma cells by repressing differentiation as well as G 1 arrest independently of the Rb signal transduction pathway. Thus, as a potent FIG. 7 . Western blot analysis of GFAP expression in T98G subclones by induction of introduced PTEN gene. Cells were seeded on Matrigel-coated (+) or uncoated (Ϫ) dishes and incubated for 72 hours at 37˚C in the presence or absence of Tc. Subsequently, cells were harvested, lysed, separated by 4 to 20% gradient SDS gels, and transferred to polyvinylidene difluoride microporous membranes, which were incubated with the anti-GFAP monoclonal antibody. The molecular weight standards (kD) are indicated on the left. Multiple bands in normal brain may represent the degraded forms of GFAP or may be due to characteristics of the anti-GFAP antibody used in this study because other researchers have reported the presence of multiple bands on Western blotting in which GFAP antibody was used in normal central nervous system. Normal brain = extracts from normal human adult cerebrum that served as a positive control; T98G = extracts from parental T98G cultured on plastic substrates. therapeutic gene ranking with p16 or p53, PTEN could be an attractive target molecule for cancer gene replacement therapy to control the growth of malignant gliomas.
Conclusions
We have demonstrated that restoration of PTEN was sufficient to suppress the growth in vitro of glioma cells containing the aberrant PTEN genes. The mechanism of growth control by PTEN was further analyzed, and we found that PTEN expression reduced the malignant phenotypes of the glioma cells by inducing not only cell cycle arrest at the G 1 phase but also astrocytic differentiation in the presence of the ECM. Therefore, gene therapy by PTEN transfer may lead to development of new modalities for the treatment of malignant glioma.
